Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Commentary: Multifactoriality of Amytrophic Lateral Sclerosis: Linking Unfolded Proteins to Oxidative Stress in Microglia

Author(s): Nadia D’Ambrosi and Cinzia Volonte

Volume 12, Issue 8, 2013

Page: [1081 - 1082] Pages: 2

DOI: 10.2174/18715273113129990113

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

21

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Primary Progressive Aphasia-Defining Genetic and Pathological Subtypes
Current Alzheimer Research

MicroRNAs-Based Therapeutic Strategy for Virally Induced Diseases
Current Drug Discovery Technologies

Bioinformatics and Protein Design
Current Pharmaceutical Biotechnology

Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
Current Gene Therapy

Metabotropic Glutamate Receptors and Interacting Proteins: Evolving Drug Targets
Current Drug Targets

Perspectives and New Aspects of Metalloproteinases’ Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine
Current Medicinal Chemistry

Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
CNS & Neurological Disorders - Drug Targets

RNA Therapeutics Directed to the Non Coding Regions of APP mRNA, In Vivo Anti-Amyloid Efficacy of Paroxetine, Erythromycin, and N-acetyl cysteine
Current Alzheimer Research

Tracking Stem Cells for Cellular Therapy in Stroke
Current Pharmaceutical Design

Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers

Pharmaceutical Strategies for Activating Sirtuins
Current Pharmaceutical Design

Denouement of Chemicals on Amyotrophic Lateral Sclerosis: Is Green Chemistry the Answer
Medicinal Chemistry

Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer’s Disease
Current Medicinal Chemistry

Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders
Current Gene Therapy

C. elegans Genetic Networks Predict Roles for O-GlcNAc Cycling in Key Signaling Pathways
Current Signal Transduction Therapy

Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
Current Pharmaceutical Design

Neuroprotection for Amyotrophic Lateral Sclerosis: Role of Stem Cells, Growth Factors, and Gene Therapy
Central Nervous System Agents in Medicinal Chemistry

Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety

Human PON Promoters: From Similarity to Prediction of Polymorphic Positions within Transcription Factor Elements
Mini-Reviews in Medicinal Chemistry

Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
CNS & Neurological Disorders - Drug Targets

© 2024 Bentham Science Publishers | Privacy Policy